Antibiotics Special Issue: Challenges and Opportunities in Antibiotic Discovery and Development
Mark A. T. Blaskovich
Abstract
ADVERTISEMENT RETURN TO ISSUEEditorialNEXTAntibiotics Special Issue: Challenges and Opportunities in Antibiotic Discovery and DevelopmentMark A. T. Blaskovich*Mark A. T. BlaskovichCentre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4072, Australia*Email: [email protected]More by Mark A. T. Blaskovichhttp://orcid.org/0000-0001-9447-2292Cite this: ACS Infect. Dis. 2020, 6, 6, 1286–1288Publication Date (Web):June 12, 2020Publication History Received18 May 2020Published online12 June 2020Published inissue 12 June 2020https://pubs.acs.org/doi/10.1021/acsinfecdis.0c00331https://doi.org/10.1021/acsinfecdis.0c00331editorialACS PublicationsCopyright © 2020 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views4929Altmetric-Citations25LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (517 KB) Get e-AlertscloseSUBJECTS:Antimicrobial agents,Bacteria,Infectious diseases,Inhibitors,Pharmaceuticals Get e-Alerts